Haemonetics Corp
HAE59.340USD
-5.695-8.76%
Cierre 02/06, 16:00（ET）Cotizaciones retrasadas 15 min
2.78BCap. mercado
16.30P/E TTM
Más Datos de Haemonetics Corp Compañía
Haemonetics Corporation is a global healthcare company. The Company is engaged in providing a suite of medical products and solutions for customers, to help them improve patient care and reduce the cost of healthcare. The Company’s technology addresses various medical markets, including blood and plasma component collection, the surgical suite, and hospital transfusion services. The Company’s Plasma segment includes plasma collection devices and disposables, donor management software and supporting software solutions sold to plasma customers. Its Blood Center segment manufactures and provides customers with its full line of apheresis solutions for automated blood collection. The Company’s Hospital segment consists of Interventional Technologies, which includes Vascular Closure, Sensor Guided Technologies and Esophageal Protection products, and Blood Management Technologies, which includes Hemostasis Management, Cell Salvage and Transfusion Management products.
Información de Haemonetics Corp
Símbolo de cotizaciónHAE
Nombre de la empresaHaemonetics Corp
Fecha de salida a bolsaOct 17, 1979
Director ejecutivoSimon (Christopher A)
Número de empleados3023
Tipo de seguridadOrdinary Share
Fin del año fiscalOct 17
Dirección125 Summer Street
CiudadBOSTON
Bolsa de valoresNASDAQ OMX NASDAQ Basic NYSE
PaísUnited States of America
Código postal02110
Teléfono17818487100
Sitio Webhttps://www.haemonetics.com
Símbolo de cotizaciónHAE
Fecha de salida a bolsaOct 17, 1979
Director ejecutivoSimon (Christopher A)
Ejecutivos de Haemonetics Corp
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Ms. Laurie A. Miller
Ms. Laurie A. Miller
Chief Human Resources Officer, Senior Vice President
Chief Human Resources Officer, Senior Vice President
28.01K
-238.00%
Mr. Charles J. Dockendorff, CPA
Mr. Charles J. Dockendorff, CPA
Independent Director
Independent Director
25.04K
+2693.00%
Mr. Robert E. Abernathy
Mr. Robert E. Abernathy
Independent Director
Independent Director
24.98K
+2693.00%
Dr. Mark W. Kroll, Ph.D.
Dr. Mark W. Kroll, Ph.D.
Independent Director
Independent Director
24.76K
+1400.00%
Ms. Michelle L. Basil, J.D.
Ms. Michelle L. Basil, J.D.
Executive Vice President, General Counsel
Executive Vice President, General Counsel
19.69K
+406.00%
Ms. Ellen M. Zane
Ms. Ellen M. Zane
Independent Chairman of the Board
Independent Chairman of the Board
19.37K
+2693.00%
Mr. Michael J. Coyle
Mr. Michael J. Coyle
Independent Director
Independent Director
15.39K
+2693.00%
Ms. Diane M. Bryant
Ms. Diane M. Bryant
Independent Director
Independent Director
7.13K
+2693.00%
Mr. Roy Galvin
Mr. Roy Galvin
Executive Vice President, Chief Commercial Officer
Executive Vice President, Chief Commercial Officer
3.24K
-145.00%
Mr. Christopher A. Simon
Mr. Christopher A. Simon
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Ver más
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Ms. Laurie A. Miller
Ms. Laurie A. Miller
Chief Human Resources Officer, Senior Vice President
Chief Human Resources Officer, Senior Vice President
28.01K
-238.00%
Mr. Charles J. Dockendorff, CPA
Mr. Charles J. Dockendorff, CPA
Independent Director
Independent Director
25.04K
+2693.00%
Mr. Robert E. Abernathy
Mr. Robert E. Abernathy
Independent Director
Independent Director
24.98K
+2693.00%
Dr. Mark W. Kroll, Ph.D.
Dr. Mark W. Kroll, Ph.D.
Independent Director
Independent Director
24.76K
+1400.00%
Ms. Michelle L. Basil, J.D.
Ms. Michelle L. Basil, J.D.
Executive Vice President, General Counsel
Executive Vice President, General Counsel
19.69K
+406.00%
Ms. Ellen M. Zane
Ms. Ellen M. Zane
Independent Chairman of the Board
Independent Chairman of the Board
19.37K
+2693.00%
Desglose de ingresos
Divisa: USDActualizado: mar., 6 de ene
Divisa: USDActualizado: mar., 6 de ene
FY2026Q2
FY2026Q1
FY2025
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2021
FY2020
FY2019
La empresa aún no ha revelado los datos relevantes.
Por regiónUSD
Nombre
Ganancia
Proporción
United States
240.09M
73.35%
Europe
42.97M
13.13%
Asia
22.57M
6.89%
Japan
18.01M
5.50%
other
3.68M
1.13%
Por negocio
Por región
La empresa aún no ha revelado los datos relevantes.
Estadísticas de accionistas
Actualizado: sáb., 31 de ene
Actualizado: sáb., 31 de ene
Accionistas
Tipos de accionistas
Accionistas
Accionistas
Proporción
BlackRock Institutional Trust Company, N.A.
11.41%
The Vanguard Group, Inc.
10.22%
Neuberger Berman, LLC
7.90%
AQR Capital Management, LLC
4.58%
State Street Investment Management (US)
3.87%
Otro
62.02%
Accionistas
Accionistas
Proporción
BlackRock Institutional Trust Company, N.A.
11.41%
The Vanguard Group, Inc.
10.22%
Neuberger Berman, LLC
7.90%
AQR Capital Management, LLC
4.58%
State Street Investment Management (US)
3.87%
Otro
62.02%
Tipos de accionistas
Accionistas
Proporción
Investment Advisor
47.59%
Investment Advisor/Hedge Fund
45.89%
Hedge Fund
9.46%
Research Firm
4.39%
Bank and Trust
1.38%
Individual Investor
1.24%
Sovereign Wealth Fund
1.14%
Pension Fund
1.03%
Family Office
0.11%
Participación institucional
Actualizado: jue., 1 de ene
Actualizado: jue., 1 de ene
Periodo del informe
Número de instituciones
Acciones mantenidas
Proporción
Cambio
2025Q4
709
51.33M
109.66%
-8.77M
2025Q3
697
54.60M
116.65%
-5.18M
2025Q2
700
57.31M
118.95%
-4.19M
2025Q1
723
57.94M
120.44%
-3.07M
2024Q4
701
58.48M
116.40%
-1.44M
2024Q3
689
57.60M
112.60%
-1.51M
2024Q2
668
57.60M
113.31%
+3.07M
2024Q1
655
52.49M
103.35%
-1.26M
2023Q4
647
51.85M
102.19%
-3.31M
2023Q3
657
52.00M
102.54%
-4.11M
Ver más
Actividad de los accionistas
Nombre
Acciones mantenidas
Proporción
Cambio
Cambio %
Fecha
BlackRock Institutional Trust Company, N.A.
5.30M
11.33%
-267.30K
-4.80%
Sep 30, 2025
The Vanguard Group, Inc.
4.82M
10.3%
-118.69K
-2.40%
Sep 30, 2025
Neuberger Berman, LLC
3.67M
7.84%
-607.17K
-14.19%
Sep 30, 2025
AQR Capital Management, LLC
2.13M
4.55%
+1.68M
+372.82%
Sep 30, 2025
State Street Investment Management (US)
1.80M
3.85%
-83.25K
-4.42%
Sep 30, 2025
River Road Asset Management, LLC
1.65M
3.54%
-886.00
-0.05%
Sep 30, 2025
Geode Capital Management, L.L.C.
1.20M
2.57%
-41.24K
-3.31%
Sep 30, 2025
Dimensional Fund Advisors, L.P.
1.10M
2.35%
+26.76K
+2.49%
Sep 30, 2025
T. Rowe Price Investment Management, Inc.
1.01M
2.16%
-583.91K
-36.61%
Sep 30, 2025
Allspring Global Investments, LLC
1.06M
2.27%
+111.31K
+11.72%
Sep 30, 2025
Ver más
ETFs relacionados
Actualizado: sáb., 6 de dic
Actualizado: sáb., 6 de dic
Nombre
Proporción
Neuberger Berman Small-Mid Cap ETF
2.34%
State Street SPDR S&P Health Care Equipment ETF
1.66%
Harbor Human Capital Factor US Small Cap ETF
1.51%
Lattice Hartford Multifactor Small Cap ETF
0.54%
Inspire Small/Mid Cap ESG ETF
0.34%
WisdomTree US SmallCap Quality Growth Fund
0.3%
Principal U.S. Small-Cap ETF
0.28%
VictoryShares US Small Mid Cap Value Momentum ETF
0.26%
Royce Quant Small-Cap Quality Value ETF
0.24%
Amplify Etho Climate Leadership U.S. ETF
0.22%
Ver más
Neuberger Berman Small-Mid Cap ETF
Proporción2.34%
State Street SPDR S&P Health Care Equipment ETF
Proporción1.66%
Harbor Human Capital Factor US Small Cap ETF
Proporción1.51%
Lattice Hartford Multifactor Small Cap ETF
Proporción0.54%
Inspire Small/Mid Cap ESG ETF
Proporción0.34%
WisdomTree US SmallCap Quality Growth Fund
Proporción0.3%
Principal U.S. Small-Cap ETF
Proporción0.28%
VictoryShares US Small Mid Cap Value Momentum ETF
Proporción0.26%
Royce Quant Small-Cap Quality Value ETF
Proporción0.24%
Amplify Etho Climate Leadership U.S. ETF
Proporción0.22%
Dividendos
Un total de
0.00
USD se ha distribuido en dividendos durante los últimos 5 años.
Fecha
Dividendos
Fecha de registro
Fecha de pago
Fecha ex-dividendo
Sin datos
División de acciones
Fecha
Fecha ex-dividendo
Tipo
Relación
Sin datos
Fecha
Fecha ex-dividendo
Tipo
Relación
Sin datos
